GleamWall
中文EN

BRTX BioRestorative Therapies, Inc.

Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1505497 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-8.5%
TTM net income YoY8.6%
TTM EPS YoY27.9%
Revenue 3-yr CAGR38.4%
Net income 3-yr CAGR—

Margins

Gross margin92.1%
Operating margin-3,975.0%
Net margin-3,089.6%
FCF margin—
EBITDA margin-3,916.2%

Returns

ROE-241.1%
ROA-147.7%
ROIC (approx.)-465.4%
Asset turnover0.05x

Leverage & solvency

Liabilities / assets34.8%
Debt / equity0.00x
Current ratio2.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.07x
Accruals ratio10.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$359,700$401,000
Cost of revenue$23,844$28,072
Gross profit$335,856$372,928
R&D expense$10.09M$6.71M
SG&A expense$5.89M$5.22M
Operating income-$15.65M-$11.56M
Pretax income-$14.20M-$8.98M
Net income-$14.24M-$8.98M
EBITDA-$15.44M-$11.37M
EPS (basic)-1.58-1.16
EPS (diluted)-1.58-1.16
Weighted avg. shares (diluted)8.99M7.76M
Banking
Net interest income$266,207$616,077
Balance sheet
Cash & equivalents$1.51M$547,890
Short-term investments$1.44M$10.18M
Receivables$15,500$188,400
Current assets$3.14M$11.14M
PP&E, net$358,767$362,936
Intangibles$534,198$623,945
Total assets$4.08M$12.28M
Current liabilities$3.72M$3.75M
Total liabilities$3.72M$3.75M
Shareholders' equity$356,744$8.53M
Shares outstanding8.88M6.92M
Cash flow statement
Operating cash flow-$10.79M-$8.23M
Capital expenditure$116,069$106,189
Free cash flow-$10.91M-$8.34M
Investing cash flow$8.90M$514,529
Financing cash flow$2.85M$7.38M
Depreciation & amortization$209,985$189,056
Stock-based compensation$3.33M$2.81M
Share buybacks$0—

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.